CYP cynata therapeutics limited

1.9 billion for chronic gvhd acquisition

  1. 1,141 Posts.
    lightbulb Created with Sketch. 218
    its chronic not acute..im sure a few posters here will highlight perfectly the difference!
    Sanofi paid 1.9.bill usd for Kadmons Rezurock..first in class treatment for chronic GVHD.

    Our IND for aGVHD, i.e second generation, one time only donor, excellent phase 1 results, no WTF is in this concotion this time around scenario!!..should get us some serious attention...

    Thats just cyp 001...Acorns and Oak trees and all that!!

    cyp 002 Cli
    cyp..oo4 OA knee.
    cyp ??..cypatch

    But we need less non execs and more full timers..especially a spat wearing go getting salesmen!!

    justa bit more research for me..but im getting there!!



 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.